BioInformatics

BioScreening.net » BioInformatics

• BioFocus to Offer IMD’s Natural Product Libraries through Drug Discovery Services
  BioFocus and InterMed Discovery (IMD) inked a marketing collaboration that will allow BioFocus to offer IMD’s natural product screening libraries through its drug discovery services. IMD will in addition provide follow-on services to BioFocus. “We have been impressed with the scale of IMD’s natural product discovery capabilities, and we believe that when InterMed’s natural product [...]
  
  
• Optimer Pharmaceuticals Receives Milestone Payment From Cempra for Next-Generation Macrolide Antibiotic
  SAN DIEGO, July 8 /PRNewswire-FirstCall/ – Optimer Pharmaceuticals, Inc. today announced it has received a $500,000 milestone payment from Cempra Pharmaceuticals, Inc. pursuant to the terms of a licensing agreement between the companies.  The milestone payment was made as a result of Cempra’s continuing development of a next-generation macrolide (CEM-101) for the treatment of respiratory [...]
  
  
• CLC bio’s enterprise platform wins award at Bio-IT World Expo in Boston
  Boston, Massachusetts, USA — April 30, 2009 — CLC bio’s enterprise platform for Next Generation Sequencing data analysis, CLC Genomics Server, has just been awarded the “Best of Show” prize at the Bio-IT World Conference & Expo 2009 – an award judged by a team of Bio-IT World magazine editors and leading industry experts. Bio-IT [...]
  
  
• A new approach to functional screening of siRNA knockdown
  KINGSTON, England, Nov. 25, 2008-Guava Technologies, Inc. presented at the recent Molecular Targets & Cancer Therapeutics Symposium* information on their recent advancements that describe an experimental methodology and the new Guava® Simplicity Analysis Software which exploit the advantages of plate based flow technology. These technological improvements result in an overall process that can significantly expedite [...]
  
  
• Virtual Screening Gives Drug Design a Boost
  San Diego, CA (OBBeC) – Researchers at the University of California, San Diego, developed a unique computational approach to identify key compounds that could lead to new drugs to combat African sleeping sickness — a disease spread by the biting tsetse fly and caused by the parasite Trypanosoma brucei. Around 150,000 people per year get [...]
  
  
• Otava develops virtual screening system
  Mathematical modelling in biology is often a problem with interactions estimation between a biomolecular target and small molecule compounds. Knowledge of this interaction allows the interruption of certain processes in cells, for example it can impede diseases such as cancer. This is why so many efforts focus on designing better models and algorithms for high-throughput [...]
  
  
• DEFINIENS AND BIOSCAN TEAM UP FOR COOPERATIVE MARKETING EFFORTS
  Morristown, New Jersey / Munich, Germany – December 2, 2008 – Definiens, the number one Enterprise Image Intelligence™ company, has signed a co-marketing agreement with Bioscan, Inc., a leading developer of advanced imaging instrumentation for radiolabeled compounds.  Under the terms of the agreement, Bioscan and Definiens will conduct cooperative marketing activities and host joint workshops [...]
  
  
• Tepnel Expands Genetic Services Portfolio with Addition of Illumina iScan Rapid Reader
  MANCHESTER, United Kingdom & STAMFORD, Conn.–Tepnel Life Sciences PLC (AIM: TED) today announced that it has expanded its molecular genetic services offering through the addition of Illumina’s iScan System, a next-generation scanner that provides researchers conducting genetic variation studies with significantly greater throughput and application diversity. This announcement marks the first anniversary of Tepnel’s new [...]
  
  
• CLC bio Signs Strategic Collaborative Agreement with J. Craig Venter Institute
  Cambridge, Massachusetts, USA — October 9, 2008 — CLC bio, a world leading full-service bioinformatics solution provider announced today an agreement with the J. Craig Venter Institute, a not-for profit genomic-focused research institute. The accord consists of a multi-year site license for the entire CLC bio bioinformatics suite of products. The goal is to implement [...]
  
  
• CLC bio Partners with Illumina to Provide Next Generation Sequencing Analysis Technology
  Aarhus, Denmark — October 2, 2008 — Following an overwhelming reception of CLC Genomics Workbench 1.0, CLC bio is happy to announce the release of its next major version of their flagship product: CLC Genomics Workbench 2.0. Additionally, CLC bio has taken another important step in leading next generation sequencing data analysis by  becoming an [...]